Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3196165 in Inflammatory Hand Osteoarthritis
NCT02683785Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2016
- Primary completion
- Nov 2017
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of otilimab in osteoarthritis (OA), sponsored by GSK. Started Mar 2016; status: completed.
02
Drugs
otilimab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02683785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683785.